Bivalent vaccines target two high-risk HPV strains, quadrivalent adds two wart-causing strains, and nonavalent covers nine strains including those causing cancers. Our own Cervavac, a quadrivalent vaccine, is a significant stride for affordability and local epidemiology. But my data from tea garden clinics in Upper Assam shows a troubling prevalence of HPV 52 and 58, genotypes not covered by these—a gap the 'nonavalent' would bridge. This is why, amid the joy of a homegrown vaccine, my researcher’s heart whispers *bhogobanor ichha* is not enough; we must tailor our shield to the very virus our soil knows.
#india#national-team
Jump in to reply — no account needed.